Supi Pharmaceutical

Jiangsu Supi Pharmaceutical Co., Ltd. is a specialized pharmaceutical company based in Changzhou, China, focused on the development and production of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. The company is particularly recognized for its expertise in the synthesis of intermediates for statin-class medications, including Atorvastatin, Rosuvastatin, and Pitavastatin. Operating from a modern manufacturing base, Supi Pharmaceutical serves the global pharmaceutical industry by providing high-purity chemical components for cardiovascular and anti-infective therapies. Their business model encompasses both independent product manufacturing and contract development and manufacturing (CDMO) services. The company maintains a strong focus on quality control and process optimization to meet international regulatory standards.